Torrey Pines Law GroupFree Consultation
≡
  • About Us
    • About Our Firm
    • The Advantages of Hiring Our Firm
    • Recent Successes
    • Client Testimonials
    • Careers
    • Diversity, Equity & Inclusion
    • Locations
    • Boston
      • Boston Patent Atorneys
      • Boston FDA Regulatory Counsel
      • Boston Technology Transactions
    • Irvine
      • Irvine Patent Atorneys
      • Irvine FDA Regulatory Counsel
      • Irvine Technology Transactions
    • Los Angeles
      • Los Angeles Patent Atorneys
      • Los Angeles FDA Regulatory Counsel
      • Los Angeles Technology Transactions
    • San Diego
      • San Diego Patent Atorneys
      • San Diego FDA Regulatory Counsel
      • San Diego Technology Transactions
    • Contact
  • Professionals
    • Meet Our Team
    • Randy Berholtz, MLitt, MBA, JD
    • Robert Buchanan, PhD, JD
    • Kevin Buckley, JD
    • Frank Chen, PhD
    • Doranne Frano, MS, MBA
    • Dmitry Kryndushkin, PhD
    • Mark Malek, JD
    • James McFarland, JD
    • Eleanor Musick, JD
    • Shihong Nicolaou, PhD
    • Steven Stupp, PhD
    • Kyle Welch, JD
    • Fawn Zhang, PharmD, JD
    •  
    • Administration
    • Jaenna Barnard
    • Carina Collins
    • Amy Stedman
    • Cyndi Willis
    •  
    • Foreign Associates
  • Intellectual Property
    • Comprehensive IP Protection
    • Patent Preparation & Prosecution
    • ● Artificial Intelligence Patents
    • ● Biotechnology Patents
    • ● Chemistry Patents
    • ● Convergence Technology Patents
    • ● In Vitro Diagnostics Patents
    • ● Lasers & Optics Patents
    • ● Medical Device Patents
    • ● Pharmaceutical Patents
    • ● Pharmaceutical Lifecycle Management
    • ● Semiconductor Patents
    • ● Software Patents
    • ● Telecommunications Patents
    • ● Telemedicine Patents
    • National Phase Entry (PCT)
    • IP Litigation
    • IP Opinions & Counseling
    • IP Resources
      • Patent Rights Overview
      • International Patent Law
      • U.S. Patent Law
        • Patent Eligibility
        • Novelty
        • Obviousness
        • Written Description
        • Enablement
      • Anatomy of a U.S. Patent
        • Utility Patent
        • Design Patent
        • Plant Patent
      • Trademark Law
      • Copyright Law
      • Trade Secrets
      • Know How
      • Intangible Assets
  • Tech Transactions
    • International Technology Transactions
    • Corporate Strategy
    • Business Agreements
    • Transactional Due Diligence
    • Intellectual Property Agreements
    • Intellectual Property Due Diligence
    • Regulatory Agreements
    • Regulatory Due Diligence
  • FDA Regulatory
    • Global Strategic Counseling
    • Dossier Submissions
    • Quality Compliance (ISO)
    • CE Mark - MDR Services
    • Digital Health
    • Hatch-Waxman & Biosimilars
    • Labeling, Advertising & Promotion
    • Reimbursement & Health Economics
  • Experience
    • Our International Experience
    • Multinational Companies
    • Public Companies
    • Private Companies
    • Research & Academic Institutions
    • Hospitals & Physicians
    • Startups & Entrepreneurs
  • Contact
background
Hide
 
Show
  • background
  • torrey-pines-broken-hill
  • torrey-pines-sunset

Comprehensive Intellectual Property Protection

Chambers Spotlight 2025 Torrey Pines Law GroupTorrey Pines Law Group has been recognized by Chambers, the premier international legal ranking organization, as a leading California intellectual property law firm. The firm’s inclusion as a top patent law firm underscores its exceptional capabilities in patent preparation and prosecution, IP legal opinions, intellectual property due diligence, pharmaceutical lifecycle management, litigation avoidance, IP transactions, and related business strategy for emerging technologies. We have also been consistently selected by The Patent Lawyer magazine as one of the Top Ten West Coast IP and patent law firms.

Each of our individual team leaders has more than 20 years of experience helping clients obtain significant international patents, regulatory approvals and clearances, and transactional success in the United States and throughout the world.

Of the many things that distinguish Torrey Pines Law Group, however, is our team's significant experience with *actually* leveraging intellectual property assets from concept to market within startups, multinational corporations, universities, private research institutes, and non-profit research foundations. This includes protecting intellectual property worldwide, closing lucrative international technology transactions, clearing complex IP, regulatory, and investment due diligence, protecting and leveraging each clinical trial hurdle, and selling FDA-regulated and unregulated products worldwide.

What makes our legal strategies truly comprehensive is our deep experience with IP strategy informing FDA regulatory strategy, which in turn informs technology transaction strategy, which in turn informs IP strategy, and so on. Each leg of this stool relies on the others to provide balance and a steady platform upon which our clients launch.

We are also good listeners. Each of our clients has a unique goal, but many of them seek a similar commercial exit through a sale, merger, acquisition, new product launch, IPO, SPAC, exclusive license, and so on. We understand the nuances of our clients' business objectives, and simply put, our clients leverage our exceptional "boots on the ground" experience to help catalyze their ventures' commercial success.

Intellectual Property:

Torrey Pines Law Group IP Successes
  • We are experts in patent preparation and prosecution with a focus on patenting the commercial embodiments of your inventions, and able to withstand validity challenges worldwide. Our team has helped major universities including the University of California, Stanford University, University of Chicago, Washington University in St. Louis, and many others with protecting basic research innovations with an eye on follow-on commercialization. Our team has helped major biopharmaceutical and electronics companies such as Pfizer, Novartis, Covidien, Mallinckrodt, Teva, Sony, and Sun Microsystems with patenting and challenging core "composition of matter" and product patents.

  • Each member of our patent team has prepared and prosecuted 100s of cutting-edge patents throughout the world related to biotechnology, pharmaceutical, medical device, artificial intelligence, convergence technologies, and chemistry and chemical engineering.
  • Our team has helped extend the patent term for multiple Active Pharmaceutical Ingredients (APIs) through complex pharmaceutical lifecycle management strategies.
  • Obtained patents on several "Orange Book listable" technologies to extend the patent term and FDA exclusivity of a small molecule pharmaceutical.
  • Secured several exclusive license agreements of both small and large molecule candidates, including sub-licenses for international manufacturing.
  • Protected trade secrets and know-how through licenses and other forms of value-created and securitized transactions.
  • Filed international trademark applications related to biotechnology, pharmaceutical, medical device, and other innovative company branding.
  • Obtained significant patent protection for Guardant Health related to multiple bioinformatics platform technologies that help pharmaceutical companies develop next-generation cancer therapies. The patent were granted in one of the most difficult art units within the US Patent & Trademark Office.
  • Obtained 10+ US patents (and additional international patents) for Dermala related to its novel microbiome balancing dermal technologies. The technology validated investments by Johnson & Johnson and several VC funds.
  • Obtained early patent protection for Singulex, under which its patent portfolio was acquired by Millipore in 2015 and incorporated into Millipore's SMCxPRO System for Single Molecule Counting.
  • Created a substantial patent portfolio which underpinned the IPO of Galera Therapeutics (NASDAQ: GRTX).
  • Obtained early patent protection for an acclaimed US private research institute, then licensed to Epic Sciences as a basis for its liquid biopsy platform.
  • Created a substantial patent portfolio for Isto Technologies which which was later acquired by Zimmer, and now used in its DeNovo NT Graft cartilage restoration products.
  • Created a novel patent portfolio for Abcore which provided significant value in its acquisition by Fortis Life Sciences.
  • Obtained 10+ US patents (and additional international patents) for CB Therapeutics related to its precision synthetic biology platform, and ultimately resulting in significant follow on investments.
  • Created a substantial patent portfolio which was licensed to MediBeacon for the commercialization of kidney function detection platform.
  • Obtained early patent protection for ProteoPlex, an antibody microarray company which was acquired by EMD Biosciences.

Life sciences, healthcare, and technology fields in which we focus include:

  • Artificial Intelligence (AI)
  • Biotechnology
  • Chemistry & Chemical Engineering
  • Convergence Technologies
  • In Vitro Diagnostics
  • Lasers & Optics
  • Medical Devices
  • Pharmaceuticals
  • Pharmaceutical Lifecycle Management
  • Semiconductors
  • Software
  • Telecommunications
  • Telemedicine

We assist clients with developing both offensive and defensive strategies in licensing, funding, regulatory, post-market, pre-litigation, and active litigation matters. This has included helping clients secure:

  • International patent protection in the world's largest economies
  • International regulatory approvals and clearances for pharmaceuticals, biotechnologies and medical devices
  • Favorable international in- and out-licenses
  • Venture capital, and other private federal, and state investments
  • Legal opinions which impact the bottom line

We welcome the opportunity to see how we can work together. You can also find us on LinkedIn®, Yelp®, and Facebook®.

≡
  • Comprehensive IP Protection
  • Patent Preparation & Prosecution
  • ● Artificial Intelligence Patents
  • ● Biotechnology Patents
  • ● Chemistry Patents
  • ● Convergence Technology Patents
  • ● In Vitro Diagnostics Patents
  • ● Lasers & Optics Patents
  • ● Medical Device Patents
  • ● Pharmaceutical Patents
  • ● Pharmaceutical Lifecycle Management
  • ● Semiconductor Patents
  • ● Software Patents
  • ● Telecommunications Patents
  • ● Telemedicine Patents
  • National Phase Entry (PCT)
  • IP Litigation
  • IP Opinions & Counseling
  • IP Resources
    • Patent Rights Overview
    • International Patent Law
    • U.S. Patent Law
      • Patent Eligibility
      • Novelty
      • Obviousness
      • Written Description
      • Enablement
    • Anatomy of a U.S. Patent
      • Utility Patent
      • Design Patent
      • Plant Patent
    • Trademark Law
    • Copyright Law
    • Trade Secrets
    • Know How
    • Intangible Assets

Chambers Spotlight California 2025 Torrey Pines Law Group   Clio Reisman Award Torrey Pines Law Group COPYRIGHT © , TORREY PINES LAW GROUP, PC. ALL RIGHTS RESERVED. | LEGAL NOTICES | SITE MAP

Torrey Pines Law Group, PC serves technology innovators with protecting intellectual property, obtaining regulatory approvals and clearances, and making deals and closing technology transactions throughout the U.S., including in major technology hubs such as San Diego, San Francisco, Palo Alto, San Jose, Silicon Valley, Boston, Cambridge, Chicago, Minneapolis, Houston, Dallas, Atlanta, Denver, Seattle, Portland, Boulder, Orlando, the Research Triangle (Raleigh, Durham, and Chapel Hill), the Mid-Atlantic (New Jersey, New York, Philadelphia, Maryland, Virginia, and Washington, DC), Pittsburgh, Cleveland, Ann Arbor, and throughout Southern California in Los Angeles, Orange County, Irvine, Torrey Pines, Sorrento Valley, and La Jolla.

We have experience with international intellectual property, regulatory and transactional matters pending in Beijing, Shanghai, Shenzhen, and Guangzhou China; Tokyo, Japan; Berlin, Munich and Frankfurt Germany; Tel Aviv Israel; Mumbai, Bengaluru, and New Delhi India; London and Edinburgh United Kingdom; Vancouver, Toronto, Calgary and Montreal Canada; Dublin, Ireland; Cape Town, South Africa; Mexico City and Tijuana Mexico; Brussels, Belgium; Copenhagen, Denmark; Paris, France; Madrid and Barcelona Spain; Moscow, Russia; Santiago, Chile; Montevideo, Uruguay; Buenos Aires, Argentina; Sao Paulo and Rio de Janeiro Brazil; Seoul, South Korea; Taipei, Taiwan; Hong Kong; Hanoi, Vietnam; Bangkok, Thailand; Kuala Lumpur, Malaysia; Milan, Italy; Singapore; Sydney, Melbourne, Perth and Adelaide Australia; Auckland, New Zealand; Oslo, Norway; Stockholm, Sweden; Helsinki, Finland; Kiev, Ukraine; Budapest, Hungary; Vienna, Austria; Prague, Czechia; Geneva and Lausanne Switzerland; Bahrain; Doha, Qatar; Abu Dhabi and Dubai UAE; and Jeddah, Saudi Arabia.

San Diego Patent Attorneys - Patent Preparation & Prosecution Counsel - Intellectual Property Litigation Law Firm